Chronic Hepatitis D Infection research hub
5 indexed studies · 3 currently recruiting
- recruitingTherapeutic use (Phase IV)
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
This study looks at people with long-lasting hepatitis D to see how a medicine called HEPCLUDEX affects their liver over about three years. It aims to understand how well the treatment helps prevent serious liver problems and if it has any side effects.
France · Austria · Germany - active not recruiting
Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
This study looks at how a medicine called bulevirtide works over time for people with chronic hepatitis D infection. Researchers want to understand its long-term effects and make sure it's safe for patients taking it.
Austria · France · Germany - not yet recruitingPHASE2
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection
This study is looking at a new medicine called ABI-6250 for people with chronic hepatitis D (HDV) infection. Researchers want to see if it's safe, how it works in the body, and if it helps treat the infection. It's a Phase 2 trial, meaning it's still in the earlier stages of testing.
France · Georgia · Germany - active not recruitingPHASE2, PHASE3
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
This study is looking at a new medicine called Brelovitug (BJT-778) for chronic Hepatitis Delta. It compares different doses of the medicine and also looks at starting treatment now versus starting it later to see how well it works and if it's safe.
United States · Australia · Bulgaria - recruitingPHASE3
A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
This study compares two new treatments, brelovitug and bulevirtide, for chronic Hepatitis Delta. It aims to see which is more effective for people with this liver condition, helping us find better long-term solutions.
Austria · Czechia · France